Found 3544 matching trials
EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC) PHASE1 Primary trial objective in this single arm trial is to assess the safety an...
Show More Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
Learn More & Join Trial
Response and Clearance of Viral DNA Following Administration of Live Attenuated Varicella Vaccine. N/A Varicella zoster virus (VZV) can lead to significant morbidity and mortalit...
Show More Location
Multiple Locations
Learn More & Join Trial
Characterization of the Inhibitory Effects of Fevipiprant (QAW039) on Activation of Eosinophils and ILC2 Cells by Prostaglandin D2 Metabolites NA The aim of this study is to draw blood from patients with well-defined atop...
Show More Location
Fraunhofer ITEM im CRC
Learn More & Join Trial
Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff N/A COVID-19 is a pathology linked to the SARS-CoV-2 virus, a new virus of the ...
Show More Location
Hôpital d'Instuction des Armées Percy
Learn More & Join Trial
Human Upper Extremity Allotransplantation PHASE2 Background: Millions of people each year sustain injuries, have tumors surg...
Show More Location
Johns Hopkins University School of Medicine
Learn More & Join Trial
Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation PHASE2 The relapse of acute leukemia, MDS and blast phase CML after allogeneic tra...
Show More Location
Emory University Winship Cancer Institute
Learn More & Join Trial
A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas PHASE1 This is a clinical trial to evaluate the feasibility and safety of giving t...
Show More Status
Active Not Recruiting
Location
Weill Cornell Medicine/NewYork-Presbyterian Hospital
Learn More & Join Trial
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs PHASE2 The goal of this prospective study is to explore the safety and preliminary...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient PHASE2 To evaluate the safety and tolerance of the combination of adefovir dipivox...
Show More Location
Phoenix Body Positive
Learn More & Join Trial
Study of MK-2206 in Patients With Metastatic Neuroendocrine Tumors (NET) PHASE2 The purpose of this study is to test a new drug called MK-2206. This study ...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial